Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ryan J Dillon"'
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Inappropriate empiric antimicrobial treatment (IET) contributes to worsened outcomes. While IET’s differential impact across types of nosocomial pneumonia (NP: non-ventilated [nvHABP], ventilated [vHABP] hospital-acquired and ve
Externí odkaz:
https://doaj.org/article/5a6cdb3e826342658199ec64cb0be666
Autor:
Richard L. Hengel, Claudia P. Schroeder, Jinhee Jo, Timothy E. Ritter, Ramesh V. Nathan, Anne J. Gonzales-Luna, Engels N. Obi, Ryan J. Dillon, Lucinda J. Van Anglen, Kevin W. Garey
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-6 (2022)
Abstract Background Clostridioides difficile infection (CDI) is associated with high recurrence rates impacting health-related quality of life (HrQOL). However, patient-reported data are lacking particularly in the outpatient setting. We assessed cha
Externí odkaz:
https://doaj.org/article/07dc502960f347a0b814aa9c7e96e398
Autor:
Aisling R. Caffrey, Haley J. Appaneal, J. Xin Liao, Emily C. Piehl, Vrishali Lopes, Ryan J. Dillon, Laura A. Puzniak, Kerry L. LaPlante
Publikováno v:
Antibiotics, Vol 11, Iss 5, p 626 (2022)
Pseudomonas aeruginosa infections are challenging to treat due to multi-drug resistance (MDR) and the complexity of the patients affected by these serious infections. As new antibiotic therapies come on the market, limited data exist about the effect
Externí odkaz:
https://doaj.org/article/df13cc8dc29f474ca63836f1e5c7ec28
Autor:
Jason Yamaki, Ryan J Dillon
Publikováno v:
Open Forum Infectious Diseases. 9
Background There are few studies describing the rationale or frequency of empiric or directed therapy treatment modification behaviors among patients with complicated Gram-negative bacterial infections (GNBI). We sought to characterize patient and tr
Publikováno v:
Open Forum Infectious Diseases. 9
Background Patients who develop AKI are at increased risk of adverse outcomes. The consequences of AKI are well-described in most therapeutic domains but there are scant data on the incidence of AKI among pts with CR-GNIs. This study sought to charac
Publikováno v:
Infectious Diseases and Therapy
Introduction Gram-negative nosocomial pneumonia (NP), including hospital-acquired bacterial pneumonia (HABP), ventilated HABP (vHABP), and ventilator-associated bacterial pneumonia (VABP), is a significant cause of morbidity and mortality. Common pat
Publikováno v:
Infectious Diseases and Therapy
Introduction The clinical efficacy and safety of ceftolozane/tazobactam for the treatment of ventilated hospital-acquired bacterial pneumonia (vHABP) and ventilator-associated bacterial pneumonia (VABP) has been demonstrated in the phase III randomis
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 953-966 (2020)
Infectious Diseases and Therapy
Infectious Diseases and Therapy
Introduction Hospital-acquired and ventilator-associated bacterial pneumonia (HABP and VABP) are associated with significant healthcare resource utilization (HCRU). This a priori, exploratory, secondary analysis from the ASPECT-NP clinical trial eval
Publikováno v:
Journal of comparative effectiveness research. 10(18)
Aim: To determine the suitability of network meta-analysis (NMA) using antibacterial treatment evidence in complicated urinary tract infection. Materials & methods: We conducted a systematic literature review to identify published clinical trial data
Autor:
Richard L, Hengel, Claudia P, Schroeder, Jinhee, Jo, Timothy E, Ritter, Ramesh V, Nathan, Anne J, Gonzales-Luna, Engels N, Obi, Ryan J, Dillon, Lucinda J, Van Anglen, Kevin W, Garey
Publikováno v:
Journal of patient-reported outcomes. 6(1)
Clostridioides difficile infection (CDI) is associated with high recurrence rates impacting health-related quality of life (HrQOL). However, patient-reported data are lacking particularly in the outpatient setting. We assessed changes in HrQOL over t